PREVALENCE OF EXCESSIVE BODY WEIGHT AND OBESITY AMONG CHILDREN; ORGANIZATION OF PREVENTION OF CHILD OBESITY IN

D Dyachuk1, Y Yaschenko2, I Zabolotna1

  • 11State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State administrative department, Kyiv.

Georgian Medical News
|June 20, 2019
PubMed

Insights

Childhood obesity prevention in Ukraine is hindered by flawed data and outdated strategies. A new socio-medical monitoring model can identify at-risk children for targeted interventions.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Policy

Background:

  • Overweight and obesity in children represent a significant public health challenge globally and in Ukraine.
  • Current prevention strategies in Ukraine are inadequate, lacking alignment with international best practices and effective data collection.
  • There is a critical need to improve the diagnosis and statistical reporting of childhood obesity to inform effective interventions.

Purpose of the Study:

  • To analyze and synthesize scientific literature and data on childhood overweight and obesity.
  • To evaluate existing prevention strategies in Ukraine against international recommendations and legal frameworks.
  • To develop and propose a model for socio-medical monitoring of childhood obesity.

Main Methods:

  • Bibliosemantic analysis of national and international scientific sources.
  • Epidemiological and content analysis of statistical databases and strategic documents.
  • Conceptual modeling for a new monitoring system.

Main Results:

  • Identified significant imperfections in statistical reporting and low diagnosis rates for childhood obesity in Ukraine.
  • Ukraine's current obesity prevention approaches do not fully incorporate evidence-based international recommendations.
  • A socio-medical monitoring model was developed to facilitate early detection and risk stratification.

Conclusions:

  • The current system for preventing childhood obesity in Ukraine requires substantial improvement, particularly in data management and strategy alignment.
  • The proposed socio-medical monitoring model offers a framework for proactive identification of children at risk.
  • Implementation of this model can lead to differentiated prevention programs, improved risk prognostication, and targeted medical care for at-risk children.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
238
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
260
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.7K
Structural Organization of the Human Body: An Overview01:18

Structural Organization of the Human Body: An Overview

It is convenient to consider the body's structures in terms of fundamental levels of organization that increase in complexity: subatomic particles, atoms, molecules, organelles, cells, tissues, organs, organ systems, and organisms.
To study the chemical level of organization, scientists consider the simplest building blocks of matter: subatomic particles, atoms, and molecules. All matter in the universe is composed of one or more unique pure substances called elements, familiar examples of...
26.9K